Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 10/20 | 0.69 |
| ▸ | FPR3 | P25089 | 3/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12040468 | 1.00 | FPR2 (0.69) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL2681701 | 1.00 | FPR2 (0.69) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL2682790 | 0.88 | FPR2 (0.67) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL856566 | 0.88 | FPR2 (0.67) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL2684236 | 0.85 | FPR2 (0.69) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL726915 | 0.85 | FPR2 (0.69) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL855563 | 0.85 | FPR2 (0.69) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL2684181 | 0.82 | FPR2 (1.00) | FPR2FPR3 | |
| SCHEMBL12040473 | 0.82 | FPR2 (0.76) | FPR2FPR3PKMALDH1A1SMN1; SMN2 | |
| SCHEMBL2683136 | 0.78 | FPR2 (1.00) | FPR2FPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432760-A1 | BRIDGED SPIRO [2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2012-03-28 | — | — | EP | disclosed |